Investor Stock List
Ranked #3,992 of 8,699 institutional investors

Avidity Partners Management LP

Dallas, TX

$434M
US stock portfolio at live prices · today +$5.1M (+1.19%)
Market closed. Prices as of Nov 20, 8:41 AM ET
Value at quarter end (Q3 2026)
$428M
Change from Q2 2026
−$196.5M (−31.47%)
Positions
17 · 0 new, 25 sold out
Filed
Nov 16, 2026

Not counted in the ranking: call options on $60.3M of stock.

Holdings

Q3 2026 13F, live prices
DNTH 37.1%CGON 25.5%ORKA 17.7%JBIO 6.94%ELVN 5.88%
StockSharesValue, live% of portfoliovs Q2 2026
DNTH Dianthus Therapeutics, Inc.1,899,593$161M37.1%Reduced −10%
CGON CG Oncology, Inc.1,348,948$110M25.5%Reduced −4%
ORKA Oruka Therapeutics, Inc.785,424$76.6M17.7%Added +3%
JBIO Jade Biosciences, Inc.2,000,000$30.1M6.94%Added +18%
ELVN Enliven Therapeutics, Inc.550,000$25.5M5.88%Unchanged
AKTS Aktis Oncology, Inc.484,200$7.9M1.83%Unchanged
IMUX Immunic, Inc.669,941$5.0M1.14%Unchanged
CATX Perspective Therapeutics, Inc.6,067,999$4.8M1.10%Reduced −4%
MOBI Mobia Medical, Inc.324,676$3.9M0.89%Reduced −59%
PVLA Palvella Therapeutics, Inc.20,000$2.9M0.67%Reduced −71%
NVCT Nuvectis Pharma, Inc.100,415$2.0M0.46%Reduced −50%
MSLE Satellos Bioscience Inc.164,019$951K0.22%Reduced −58%
SENS Senseonics Holdings, Inc.100,000$890K0.21%Reduced −94%
CNTX Context Therapeutics Inc.4,060,254$685K0.16%Reduced −19%
AVLN Avalyn Pharma Inc.20,000$574K0.13%Reduced −67%
SCYX SCYNEXIS, Inc.153,613$400K<0.1%Reduced −41%
KPTIQ Karyopharm Therapeutics Inc.884,900$30K<0.1%Reduced −4%

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
RGEN Repligen Corporation77,800$13.2M
DXCM DexCom, Inc.100,000$8.0M
TEM Tempus AI, Inc.105,000$6.3M
EHC Encompass Health Corporation42,000$5.6M
VIR Vir Biotechnology, Inc.519,300$4.6M
BSX Boston Scientific Corporation80,000$3.4M
GILD Gilead Sciences, Inc.20,000$3.3M
PODD Insulet Corporation24,000$3.3M
CRL Charles River Laboratories International, Inc.10,000$3.3M
ALMR Alamar Biosciences, Inc.110,000$3.2M
GMAB Genmab A/S50,000$2.6M
GPCR Structure Therapeutics Inc.98,000$1.7M
ABT Abbott Laboratories10,000$1.0M
PHAT Phathom Pharmaceuticals, Inc.200,000$1.0M
KLRA Kailera Therapeutics, Inc.80,000$926K
CRVS Corvus Pharmaceuticals, Inc.80,000$801K
BBIO BridgeBio Pharma, Inc.10,000$782K
NTLA Intellia Therapeutics, Inc.75,000$714K
EVMN Evommune Inc75,000$543K
PTON Peloton Interactive, Inc.100,000$507K
TENX Tenax Therapeutics, Inc.265,934$370K
SVRA Savara Inc.50,000$261K
LEGN Legend Biotech Corporation15,000$242K
TRVI Trevi Therapeutics, Inc.6,660$91K
BBOT BridgeBio Oncology Therapeutics, Inc.43,853$82K